We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioseek | LSE:ATD | London | Ordinary Share | GB0009231639 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMATD
RNS Number : 8599F
Asterand PLC
04 May 2011
For Immediate Release 4 May 2011
ASTERAND PLC
('Asterand' or 'the Company')
Notification of Today's Webcast of 2010 Final Results
Asterand plc ("Asterand" or the "Group" - LSE: ATD), a leading supplier of human tissue based solutions to pharmaceutical and biotechnology companies engaged in drug discovery research announced its Final Results for the year ended 31 December 2010, on Thursday 28 April 2011.
Today an analyst briefing will be held at 10:00am BST at the offices of Buchanan Communications, 107 Cheapside, EC2V 6DN.
Simultaneously to the analyst briefing, there will be a live audio web cast of the presentation.
To connect to the web cast facility, please go to: http://mediaserve.buchanan.uk.com/2011/asterand040511/registration.asp
Please connect approximately 10 minutes (9:50 am BST) before the start of the briefing. The presentation will also be available on www.buchanan.uk.com for replay shortly after the conclusion of the presentation.
A recording of the webcast will also be made available on the Company website.
- Ends -
Contacts:
Asterand plc Martyn Coombs, Chief Executive Tel: + 44 (0) 1763 211 600 / + 1 (313) Officer 263-0960 John Stchur, Chief Financial As above Officer Buchanan Communications Lisa Baderoon / Mark Court Tel: +44 (0) 20 7466 5000 / Isabel Podda Daniel Stewart & Company plc Antony Legge Tel: +44 (0) 20 7776 6566
About ASTERAND
Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market.
For more information, go to www.Asterand.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQXLFBFEFXBBB
1 Year Bioseek Chart |
1 Month Bioseek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
